Ludwig Institute for Cancer Research
The Ludwig Institute for Cancer Research is a global non profit organization committed to improving the understanding and control of cancer through integrated laboratory and clinical discovery. Leveraging its worldwide network of investigators and the ability to sponsor and conduct its own clinical trials, the Institute is actively engaged in translating its discoveries into applications for human benefit.
Program Highlights
Human Cancer Genome Project
In 1999, LICR and FAPESP (The State of São Paulo Research Foundation) initiated the multi-million dollar HCGP to identify genes expressed in cancer, by comparing expressed sequence tags (ESTs) from tumor samples and normal tissues. In 2003, LICR and the U.S. National Cancer Institute combined their respective data sets to create the largest, publicly-available EST database, the Cancer Genome Anatomy Project (CGAP). These data enabled the identification of genes in the newly-completed sequencing of the human genome (Human Genome Project). More »
News
Jeanne Tie, MD, from the Melbourne Branch of the international Ludwig Institute for Cancer Research was presented with The Bradley Stuart Beller Merit Award at an awards ceremony held at the American Society of Clinical Oncology (ASCO) annual meeting in Florida.
Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have uncovered a remarkable property of the contractile ring, a structure required for cell division. Understanding how the contractile ring works to divide the cell may facilitate development of therapies to prevent uncontrolled cell division in cancer.